BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lee EC, Kim SH, Shim JR, Park SJ. A comparison of desensitization methods: Rituximab with/without plasmapheresis in ABO-incompatible living donor liver transplantation.Hepatobiliary Pancreat Dis Int. 2018;17:119-125. [PMID: 29576278 DOI: 10.1016/j.hbpd.2018.02.005] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Han C, Wei Q, Yang M, Zhuang L, Xu X. The critical role of therapeutic plasma exchange in ABO-incompatible liver transplantation. Hepatobiliary & Pancreatic Diseases International 2022. [DOI: 10.1016/j.hbpd.2022.06.019] [Reference Citation Analysis]
2 Komagome M, Maki A, Nagata R, Masuda W, Kogure R, Mitsui T, Ninomiya R, Akamatsu N, Hasegawa K, Beck Y. Refractory Acute Antibody Mediated Rejection in Liver Transplant After Desensitization of Preformed Donor Specific Antibody-Validity of Bortezomib and Everolimus: A Case Report. Transplant Proc 2022;54:147-52. [PMID: 34974892 DOI: 10.1016/j.transproceed.2021.11.022] [Reference Citation Analysis]
3 Lee WC, Lee CF, Wu TH, Hung HC, Lee JC, Wang YC, Cheng CH, Wu TJ, Chou HS, Chan KM. Clinical Relevance of Isoagglutinin Rebound in Adult ABO-Incompatible Living Donor Liver Transplantation. J Pers Med 2021;11:1300. [PMID: 34945772 DOI: 10.3390/jpm11121300] [Reference Citation Analysis]
4 Lee B, Cho JY, Han HS, Yoon YS, Lee HW, Lee JS, Kim M, Choi Y. Long-term outcomes of emergency ABO-incompatible living donor liver transplantation using a modified desensitization protocol for highly sensitized patients with acute liver failure: A case report. Ann Hepatobiliary Pancreat Surg 2021;25:571-4. [PMID: 34845134 DOI: 10.14701/ahbps.2021.25.4.571] [Reference Citation Analysis]
5 Skogsberg Dahlgren U, Herlenius G, Gustafsson B, Mölne J, Rydberg L, Socratous A, Bennet W. Excellent outcome following emergency deceased donor ABO-incompatible liver transplantation using rituximab and antigen specific immunoadsorption. Scand J Gastroenterol 2021;:1-10. [PMID: 34541993 DOI: 10.1080/00365521.2021.1976269] [Reference Citation Analysis]
6 Mohamed M, Sweeney T, Alkhader D, Nassar M, Alqassieh A, Lakhdar S, Nso N, Fülöp T, Daoud A, Soliman KM. ABO incompatibility in renal transplantation. World J Transplant 2021; 11(9): 388-399 [PMID: 34631470 DOI: 10.5500/wjt.v11.i9.388] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Markiewicz-Kijewska M, Kaliciński P, Torres Canizales J, Di Giorgio A, Baumann U, Jorns C, Baker A, Lopes MF, Frauca Remacha E, Lopez-Granados E, Jara Vega P, Basso MS, Kowalewski G, Kamińska D, Ferreira S, Liccardo D, Pietrobattista A, Spada M, On Behalf Of Ern TransplantChild Healthcare Working Group. ABO Incompatible Liver Transplantation in Children: A 20 Year Experience from Centres in the TransplantChild European Reference Network. Children (Basel) 2021;8:760. [PMID: 34572193 DOI: 10.3390/children8090760] [Reference Citation Analysis]
8 Lin YC, Lin TS, Lin CC, Liu YW, Wang SH, Wu YJ, Li WF, Lin YH, Lin TL, Chan YC, Yeh CH, Wang CC, Chen CL, Yong CC. Can Microscopic Biliary Reconstruction Reduce Biliary Complication Rate in ABO-Incompatible Adult Living Donor Liver Transplantation? Ann Transplant 2021;26:e931963. [PMID: 34446690 DOI: 10.12659/AOT.931963] [Reference Citation Analysis]
9 Saitoh Y, Fujio A, Miyagi S, Tokodai K, Unno M, Kamei T. ABO-incompatible living donor liver transplantation with high preoperative antibody titer: A case report. Int J Surg Case Rep 2021;85:106260. [PMID: 34343790 DOI: 10.1016/j.ijscr.2021.106260] [Reference Citation Analysis]
10 Zhang Y, Zhang J, Yi H, Zheng J, Cai J, Chen W, Lu T, Chen L, Du C, Liu J, Yao J, Zhao H, Wang G, Fu B, Zhang T, Zhang J, Wang G, Li H, Xiang AP, Chen G, Yi S, Zhang Q, Yang Y. A novel MSC-based immune induction strategy for ABO-incompatible liver transplantation: a phase I/II randomized, open-label, controlled trial. Stem Cell Res Ther 2021;12:244. [PMID: 33863383 DOI: 10.1186/s13287-021-02246-4] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Kaplan B, Bonagura VR. Secondary Hypogammaglobulinemia: An Increasingly Recognized Complication of Treatment with Immunomodulators and After Solid Organ Transplantation. Immunol Allergy Clin North Am 2019;39:31-47. [PMID: 30466771 DOI: 10.1016/j.iac.2018.08.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
12 Oh J, Kim JM. Immunologic strategies and outcomes in ABO-incompatible living donor liver transplantation. Clin Mol Hepatol 2020;26:1-6. [PMID: 30909688 DOI: 10.3350/cmh.2019.0023] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
13 Chu KK, Chok KS, Fung JY, Chan AC, Dai WC, Lo CM. Emergency ABO-incompatible living donor liver transplant for patients with ultrahigh MELD scores. Hepatobiliary Pancreat Dis Int 2019;18:87-9. [PMID: 30518484 DOI: 10.1016/j.hbpd.2018.11.006] [Reference Citation Analysis]
14 Kok B, Dong V, Karvellas CJ. Graft Dysfunction and Management in Liver Transplantation. Crit Care Clin 2019;35:117-33. [PMID: 30447775 DOI: 10.1016/j.ccc.2018.08.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]